Lord, Abbett & Co
CAH icon

Lord, Abbett & Co’s Cardinal Health CAH Stock Holding History

Lord, Abbett & Co’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-269,000
Closed -$25.4M – 535
2023
Q2 		$25.4M Buy
+269,000
New +$22.7M 0.09% 295
2023
Q1 		– Sell
-443,000
Closed -$34.1M – 557
2022
Q4 		$34.1M Sell
443,000
-66,500
-13% -$5.05M 0.12% 245
2022
Q3 		$34M Buy
+509,500
New +$32.3M 0.12% 215
2019
Q1 		– Sell
-95,000
Closed -$4.24M – 717
2018
Q4 		$4.24M Sell
95,000
-421,900
-82% -$22M 0.02% 676
2018
Q3 		$27.9M Sell
516,900
-317,200
-38% -$16.2M 0.08% 401
2018
Q2 		$40.7M Sell
834,100
-663,000
-44% -$37.6M 0.12% 271
2018
Q1 		$93.8M Buy
1,497,100
+241,100
+19% +$16.5M 0.28% 82
2017
Q4 		$77M Sell
1,256,000
-31,800
-2% -$1.97M 0.22% 128
2017
Q3 		$86.2M Buy
1,287,800
+54,800
+4% +$3.87M 0.25% 107
2017
Q2 		$96.1M Buy
1,233,000
+223,914
+22% +$16.9M 0.29% 85
2017
Q1 		$82.3M Buy
1,009,086
+50,000
+5% +$3.94M 0.25% 113
2016
Q4 		$69M Sell
959,086
-3,956
-0.4% -$286K 0.21% 142
2016
Q3 		$74.8M Sell
963,042
-124,715
-11% -$10.1M 0.23% 124
2016
Q2 		$84.9M Sell
1,087,757
-208,000
-16% -$16.6M 0.27% 89
2016
Q1 		$106M Sell
1,295,757
-162,400
-11% -$13.2M 0.33% 64
2015
Q4 		$130M Buy
1,458,157
+323,300
+28% +$27.5M 0.39% 44
2015
Q3 		$87.2M Sell
1,134,857
-343,217
-23% -$28.7M 0.26% 99
2015
Q2 		$124M Buy
1,478,074
+98,374
+7% +$8.69M 0.33% 60
2015
Q1 		$125M Buy
1,379,700
+195,127
+16% +$16.8M 0.32% 73
2014
Q4 		$95.6M Sell
1,184,573
-3,482
-0.3% -$275K 0.24% 102
2014
Q3 		$89M Buy
1,188,055
+85,719
+8% +$6.24M 0.22% 111
2014
Q2 		$75.6M Sell
1,102,336
-201,203
-15% -$13.7M 0.17% 161
2014
Q1 		$91.2M Buy
1,303,539
+72,247
+6% +$5.02M 0.21% 140
2013
Q4 		$82.3M Sell
1,231,292
-895,872
-42% -$54.8M 0.18% 156
2013
Q3 		$111M Buy
2,127,164
+1,265,864
+147% +$64.3M 0.26% 106
2013
Q2 		$40.7M Buy
+861,300
New +$39.3M 0.09% 314

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lord, Abbett & Co's CAH Position: Q3 2023 in Review

Lord, Abbett & Co sold out of Cardinal Health (CAH) in Q3 2023, closing a stake of 269,000 shares — an estimated $25.4M sold.

Lord, Abbett & Co first reported a position in CAH in Q2 2013 and held it in 26 quarters. The position peaked at $130M in Q4 2015. 949 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

  • Lord, Abbett & Co reported no remaining Cardinal Health position as of Q3 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 269,000 Cardinal Health shares in Q3 2023, an estimated $25.4M.
  • Lord, Abbett & Co first reported a position in Cardinal Health in Q2 2013 and held it in 26 quarters.
  • Lord, Abbett & Co's Cardinal Health position peaked at $130M in Q4 2015.
  • 949 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on Lord, Abbett & Co's 13F filing for Q3 2023, filed 13 Nov 2023.